Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis
Damian R. Plichta(Broad Institute), Ramnik J. Xavier(Massachusetts General Hospital), Matthieu Pichaud(Novartis (United States)), Cory A. Perugino(Harvard University), John H. Stone(Twitter (United States)), Harri Lähdesmäki(Aalto University), Hera Vlamakis(Broad Institute), Ana D. Fernandes(Universidade do Estado do Rio de Janeiro), Juhi Somani(Aalto University), Shiv Pillai(Ragon Institute of MGH, MIT and Harvard), Dinesh Khanna(University of Michigan), Daniel C. Chung(Massachusetts General Hospital), Zachary S. Wallace(Amgen (United States))
Cited by 59
Related Papers
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k